<

SANOFI-AVENTIS (EPA:SAN) Press Release: FDA approves once-weekly ALTUVIIIO™, a new class of factor VIII therapy for hemophilia A that offers significant bleed protection

Transparency directive : regulatory news

23/02/2023 22:00



Other stories

09/06/2023 23:31
09/06/2023 21:52
09/06/2023 13:54
09/06/2023 19:34
09/06/2023 18:45
09/06/2023 17:57
09/06/2023 14:21
09/06/2023 17:06
09/06/2023 16:27
09/06/2023 16:52
09/06/2023 17:48
09/06/2023 13:01
09/06/2023 15:15
09/06/2023 16:15
09/06/2023 21:50
09/06/2023 17:56
09/06/2023 14:43
09/06/2023 20:33
09/06/2023 07:00
08/06/2023 21:36
08/06/2023 10:56
08/06/2023 22:06
09/06/2023 18:25
09/06/2023 16:25
09/06/2023 13:03
09/06/2023 15:38
09/06/2023 21:26
09/06/2023 23:15
09/06/2023 18:00
09/06/2023 18:09
09/06/2023 10:37
09/06/2023 20:14
08/06/2023 20:47
09/06/2023 20:25
09/06/2023 12:54
09/06/2023 11:26
09/06/2023 05:57
09/06/2023 12:56